Curaleaf Holdings, Inc.

C$13.23As of Sun 8 Nov 2026, 12:00 UTC
TSX:CURAHealthcare
Country Canada
PE (Fwd) •••
TSR 8Y CAGR (9.12%)
Div yield —
ROE (0.50%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.76
PE TTM —
TSR TTM 11.65%
Mkt cap C$3.506B
ROIC 0.57%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$16
24.13%
88.58%
Hold 9|12|9|12|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.25
0.25
0.26
0.26
18.02%
17.82%
9.52%
4.63%
Revenue$M
183.1
182.9
187.8
189.2
9.55%
3.25%
6.90%
8.33%
Peers (US$2.482B)
Cap (US$)
PE
1.330B
23.31x
Capital
TTM
5Y
10Y
Leveragex
11.00
0.166
0.133
EBIT/Intx
3.337
0.553
0.459
Own earn%
(159.20)
13.34
14.74
Sh yield%
17.82
51.78
50.72
Owners
Insiders/Inst%
13.97
68.76
Short interest%
2.67
SBC / revenue%
4.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
17